Company valuation ยท Healthcare

HCSG: Hold with a $21.54 price target

Healthcare Services Group Inc. The company returned to profit, but less cash remains for each dollar of profit.

Model target ยท USD
$21.54
For 2027-09-17
Model rating
Hold
Reviewed 2026-09-17
Reference weekly close
$21.98
2026-09-11 ยท USD
Editorial illustration of Healthcare Services Group Inc, Medical Care Facilities.
Generated editorial illustration for Sharemaestro. It does not depict verified company premises or events.

Investment view

The company returned to profit, but less cash remains for each dollar of profit.

Target and reference price

Target for 2027-09-17: $21.54 USD, -2.0% versus the $21.98 weekly close on 2026-09-11. Price return only; dividends, fees and tax excluded.

Price and earnings

Over 1 year (2025-09-12 to 2026-09-11), price changed +37.2% and trailing EPS changed +1119.0%. A wider gap changes the earnings multiple; it does not establish fair value.

Supporting evidence

Net income was 22.7m, compared with -32.4m in the same quarter last year. Amounts are in USD.

Net debt / EBITDA: -1.0ร— for HCSG, against 2.8ร— across 12 comparable peers.

Risks to the case

Cash after capital spending / profit: 1.2ร— for HCSG, against 2.7ร— across 6 comparable peers.

What to monitor

Compare the next results with the trailing margin of 7.0% and the annual-history median of 3.1%. A historical median is context, not a forecast.

The latest quarterly margin changed +13.8 percentage points from a year earlier. Check sales volumes, pricing and unusual gains in the next filing.

Recheck the valuation gap alongside profitability and growth after new results. A discount alone does not establish value.

Valuation assumptions

Starting annual sales growth: 4.98%.

Net profit margin: 4.45%.

About this assessment

Review recorded on 2026-09-17. This is a dated summary of an automated company valuation. The full report includes the financial evidence, alternative scenarios and review history. Consult the latest report before using an earlier target. Automated model research, not personal investment advice. Targets depend on assumptions; returns are not guaranteed.

Evidence context